Anthony R Means

Title: Innovations of Anthony R Means in Cancer and Obesity Treatment

Introduction

Anthony R Means is a prominent inventor based in Chapel Hill, NC (US). He has made significant contributions to the fields of cancer and obesity treatment through his innovative research and patented inventions. With a total of 4 patents, Means has focused on developing methods and compounds that target critical pathways in these diseases.

Latest Patents

One of Means' latest patents is centered on CaMKK-β as a target for treating cancer. This patent provides compounds and pharmaceutical compositions that exhibit anti-cancer activity. It also outlines methods for diagnosing, detecting, and treating cancer in subjects, including evaluating cancer stages by determining the amount of Ca/calmodulin dependent kinase kinase (CaMKK) in a sample. Another significant patent addresses CaMKK-β as a target for treating obesity. This invention describes a method for treating conditions such as obesity and insulin resistance by administering a CaMKK inhibitor in a treatment-effective amount.

Career Highlights

Anthony R Means is affiliated with Duke University, where he conducts his research and develops his innovative solutions. His work has garnered attention for its potential impact on public health, particularly in addressing the growing concerns of cancer and obesity.

Collaborations

Means has collaborated with notable colleagues, including Donald P McDonnell and Daniel Frigo, to advance his research and enhance the effectiveness of his inventions.

Conclusion

Anthony R Means continues to be a leading figure in the innovation of treatments for cancer and obesity, with his patents paving the way for future advancements in these critical areas of health. His contributions are vital in the ongoing battle against these diseases.